The shares of Chinese giant Alibaba (BABA.US) have come under pressure amid news that one of its large institutional shareholders, SoftBank, has almost sold shares worth more than $7.2 billion. The institution reduced its stake to 3.8%, and the sale took place on the over-the-counter market.
- The chairman of the Japanese institution that made the sale - Masayoshi Son - was one of the first people to help Alibaba grow, with a $20 million investment in 2000. Son stepped down from Alibaba's board in 2020, shortly after company co-founder Jack Ma resigned from SoftBank's board;
- The institution acquired a 25% stake in Alibaba roughly three years ago, for about $100 billion. At the time, the company was SoftBank's largest investment. Since then, SoftBank has suffered huge losses, with its VisionFund reporting $5 billion in losses in February, due to a slowdown in the technology sector that has weighed down valuations - including of Chinese businesses;
- Alibaba operates in several sectors including e-commerce and technology, and there have been recent reports of the spin-off of its 6 individual units. The reports eased concerns about the state's influence on China's private sector and appealed to investors. They also fueled a rebound in the Chinese stock market.
Alibaba (BABA.US) shares, D1 interval. Bulls in the near term have to overcome the 38.2 Fibonacci retracement of the upward wave initiated in the fall of 2022 if they want to maintain momentum. The main support is set by the SMA200 average (red line) - as long as the price is above it, the trend remains upward. Source: xStation5
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appThe content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
